How does age determine the development of human immune-mediated arthritis?

Area of Science:

• Immunology
• Rheumatology
• Pediatrics

Background:

• Children typically exhibit 'immune privilege,' resisting immune-mediated joint inflammation in their first year.
• Juvenile idiopathic arthritis (JIA) signifies a loss of this privilege, leading to chronic inflammation.
• JIA shares characteristics with adult arthritis phenotypes, including autoantibody profiles and disease patterns.

Purpose of the Study:

• To explore mechanisms underlying the age-dependent emergence of immune-mediated arthritis.
• To discuss hypotheses explaining the differences and similarities in immune tolerance loss between children and adults.
• To establish a framework for understanding arthritis pathogenesis across all age groups.

Main Methods:

• Review and synthesis of current research on immune-mediated arthritis.
• Exploration of genetic, epigenetic, immune maturation, environmental, and comorbidity factors.
• Development of three core hypotheses regarding age-related arthritis development.

Main Results:

• Identified key factors contributing to the shift from immune privilege to chronic inflammation in JIA.
• Proposed three interconnected hypotheses: a critical window in genetics/epigenetics, immune system maturation, and accumulated burden.
• Highlighted the variability in underlying mechanisms among individuals.

Conclusions:

• Age is a critical factor in the onset and presentation of immune-mediated arthritis.
• A comprehensive understanding requires integrating genetic, epigenetic, immunological, environmental, and comorbidity influences.
• Further research into these mechanisms will facilitate an integrated view of arthritis pathogenesis across the lifespan.